Praxisgemeinschaft Jerichow Schulze
- Address
- Johannes-Lange-Str. 20, 39319 Jerichow, Germany
Cardiovascular Diseases
Praxisgemeinschaft Jerichow Schulze is advancing research in cardiovascular diseases, targeting conditions such as hypertension, high cardiovascular risk, and established heart disease. The studies aim to test new therapies that may lower the incidence of heart attacks, strokes, and heart‑failure events while ensuring safety and tolerability.
- Risk reduction in cardiovascular mortality
- Management of hypertension
- Evaluation of novel peptide therapeutics
At this German research site, investigators are evaluating innovative approaches to protect heart health and improve long‑term outcomes for patients.
Digestive System Diseases
The centre also focuses on digestive system diseases, specifically irritable bowel syndrome and ulcerative colitis. Clinical trials assess the efficacy and safety of agents such as MYRRHINIL‑INTEST for IBS‑D/M and compare biologics like risankizumab with existing treatments to achieve symptom relief and sustained remission.
- Therapeutic options for IBS‑D and IBS‑M
- Biologic comparisons for ulcerative colitis
- Patient‑reported outcome improvements
Research at this site seeks to bring more effective, well‑tolerated treatments to individuals living with chronic gastrointestinal disorders.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
- 1Alnylam Pharmaceuticals Inc.1active
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Praxisgemeinschaft Jerichow Schulze
lock Showing 1 of 3 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Comparative Efficacy and Safety of Risankizumab Versus Vedolizumab in Adult Patients With Moderate to Severe Ulcerative Colitis Naïve to Targeted Therapies | AbbVie Deutschland GmbH & Co. KG | Phase III | Not Recruiting | Jul 2025 | — |
IMP list
lock Showing 1 of 6 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Coffee Charcoal | 1 | Unknown | 2020-05-05 | 2020-05-05 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.